{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:10:46Z","timestamp":1771513846161,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","award":["JR20\/00019"],"award-info":[{"award-number":["JR20\/00019"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","award":["FIS 2021 - PI21\/01653"],"award-info":[{"award-number":["FIS 2021 - PI21\/01653"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","award":["FIS 2024 - PI24\/00982"],"award-info":[{"award-number":["FIS 2024 - PI24\/00982"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ayuda SEOM - Juan Rod\u00e9s 2020"},{"name":"EURATOM Horizon 2020","award":["900009 \u2014 NFRP-2019-2020"],"award-info":[{"award-number":["900009 \u2014 NFRP-2019-2020"]}]},{"name":"Programa CRIS Contra el C\u00e1ncer Talento M\u00e9dico Investigador 2024"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer is one of the main causes of morbidity and mortality in Spain and has a significant impact in the workplace, where exposure to carcinogens in the work environment can increase the risk of developing this disease. The lack of communication between oncologists and occupational physicians limits the accurate assessment of cancer as an occupational disease and as a cause of disability. In 2020, the Spanish Society of Medical Oncology (SEOM) and the Spanish Association of Occupational Medicine Specialists (AEEMT) launched a joint initiative to strengthen prevention, reporting, and management of occupational cancer. This consensus provides a structured framework for assessing the occupational origin of cancer, facilitating case notification and classification as occupational contingencies, and supporting informed evaluations of disability and work reintegration in patients with cancer. The collaboration between both societies aims not only to advance occupational cancer prevention but also to promote evidence-based strategies for return-to-work planning.<\/jats:p>","DOI":"10.1007\/s12094-025-04037-2","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:12:06Z","timestamp":1757999526000},"page":"880-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SEOM-AEEMT consensus on occupational cancer and cancer-associated disability"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-7338","authenticated-orcid":false,"given":"Laura","family":"Mezquita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Te\u00f3fila","family":"Vicente-Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Victoria Ram\u00edrez \u00cd\u00f1iguez","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hidalgo-Coloma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa Capdevila","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aitana","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerine","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"P\u00e9rez-Altozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Garc\u00eda-Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Guti\u00e9rrez-Sainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Moreno-Atahonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Or\u00e9-Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Terradillos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Rosario","family":"Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Reinoso-Barbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar A.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Calvo-Cerrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The SEOM - Environmental, Occupational Cancer Working Group, the AEEMT - Functional Group on Cancer, Work","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"4037_CR1","unstructured":"El c\u00e1ncer en cifras | SEOM: Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/seom.org\/publicaciones\/el-cancer-en-espanyacom."},{"key":"4037_CR2","unstructured":"Agents classified by the IARC Monographs, volumes 1\u2013138 [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/monographs.iarc.who.int\/agents-classified-by-the-iarc."},{"key":"4037_CR3","unstructured":"Portal INSST [Internet]. [cited 2025 Apr 21]. Inforcarquim: Procedimientos Carcin\u00f3genos o Cancer\u00edgenos - Portal INSST - INSST. Available from: https:\/\/www.insst.es\/agentes-quimicos-infocarquim\/procedimientos."},{"key":"4037_CR4","unstructured":"Kogevinas M, Casta\u00f1o Vinyals G, Rodr\u00edguez Su\u00e1rez MM, Tard\u00f3n Garc\u00eda A, Serra C. Estimaci\u00f3n de la incidencia y mortalidad por c\u00e1ncer laboral en Espa\u00f1a, 2002. Archivos de prevenci\u00f3n de riesgos laborales [Internet]. 2008 [cited 2025 Apr 21];11(4):180\u20137. Available from: https:\/\/dialnet.unirioja.es\/servlet\/articulo?codigo=2743439. ISSN-e 1578-2549, ISSN 1138-9672."},{"key":"4037_CR5","unstructured":"Ministerio de Sanidad - \u00c1reas - Salud laboral - C\u00e1ncer atribuible al trabajo [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.sanidad.gob.es\/areas\/saludLaboral\/cancerTrabajo\/home.htm."},{"key":"4037_CR6","doi-asserted-by":"crossref","unstructured":"Blot WJ, Tarone RE. Doll and Peto\u2019s quantitative estimates of cancer risks: holding generally true for 35 years. J Natl Cancer Inst [Internet]. 2015 Apr 1 [cited 2020 Sep 24];107(4). Available from: https:\/\/academic.oup.com\/jnci\/article\/107\/4\/djv044\/894954.","DOI":"10.1093\/jnci\/djv044"},{"key":"4037_CR7","unstructured":"BOE-A-2015-11724 Real Decreto Legislativo 8\/2015, de 30 de octubre, por el que se aprueba el texto refundido de la Ley General de la Seguridad Social. [Internet]. [cited 2023 Apr 16]. Available from: https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2015-11724."},{"key":"4037_CR8","unstructured":"BOE-A-2006-22169 Real Decreto 1299\/2006, de 10 de noviembre, por el que se aprueba el cuadro de enfermedades profesionales en el sistema de la Seguridad Social y se establecen criterios para su notificaci\u00f3n y registro. [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2006-22169."},{"key":"4037_CR9","unstructured":"Seguridad Social: Estad\u00edsticas [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.seg-social.es\/wps\/portal\/wss\/internet\/EstadisticasPresupuestosEstudios\/Estadisticas\/EST231\/2083."},{"key":"4037_CR10","unstructured":"European Commission. Directorate General for Employment, Social Affaires and Equal Opportunities. Information notices on occupational diseases a guide to diagnosis. [Internet]. LU: Publications Office; 2009 [cited 2025 Apr 21]. Available from: https:\/\/data.europa.eu\/doi\/10.2767\/38249."},{"key":"4037_CR11","unstructured":"Loomis D, Guha N, Al Hall KS. Identifying occupational carcinogens: an update from the IARC Monographs. PubMed [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29769352\/."},{"key":"4037_CR12","unstructured":"Ministerio de la Presidencia, Justicia y Relaciones con las Cortes. Real Decreto 612\/2024, de 2 de julio, por el que se modifica el Real Decreto 665\/1997, de 12 de mayo, sobre la protecci\u00f3n de los trabajadores contra los riesgos relacionados con la exposici\u00f3n a agentes cancer\u00edgenos durante el trabajo [Internet]. Sect. 1, Real Decreto 612\/2024 Jul 3, 2024, p. 82090\u2013104. Available from: https:\/\/www.boe.es\/eli\/es\/rd\/2024\/07\/02\/612."},{"key":"4037_CR13","unstructured":"Ministerio de la Presidencia, Relaciones con las Cortes y Memoria Democr\u00e1tica. Real Decreto 427\/2021, de 15 de junio, por el que se modifica el Real Decreto 665\/1997, de 12 de mayo, sobre la protecci\u00f3n de los trabajadores contra los riesgos relacionados con la exposici\u00f3n a agentes cancer\u00edgenos durante el trabajo [Internet]. Sect. 1, Real Decreto 427\/2021 Jun 16, 2021, p. 73376\u201381. Available from: https:\/\/www.boe.es\/eli\/es\/rd\/2021\/06\/15\/427."},{"key":"4037_CR14","unstructured":"Ministerio de Empleo y Seguridad Social. Real Decreto 1150\/2015, de 18 de diciembre, por el que se modifica el Real Decreto 1299\/2006, de 10 de noviembre, por el que se aprueba el cuadro de enfermedades profesionales en el sistema de la Seguridad Social y se establecen criterios para su notificaci\u00f3n y registro [Internet]. Sect. 1, Real Decreto 1150\/2015 Dec 19, 2015, p. 119720\u20132. Available from: https:\/\/www.boe.es\/eli\/es\/rd\/2015\/12\/18\/1150."},{"key":"4037_CR15","unstructured":"Ministerio de Empleo y Seguridad Social. Real Decreto 257\/2018, de 4 de mayo, por el que se modifica el Real Decreto 1299\/2006, de 10 de noviembre, por el que se aprueba el cuadro de enfermedades profesionales en el sistema de la Seguridad Social y se establecen criterios para su notificaci\u00f3n y registro [Internet]. Sect. 1, Real Decreto 257\/2018 May 5, 2018, p. 48047\u20139. Available from: https:\/\/www.boe.es\/eli\/es\/rd\/2018\/05\/04\/257."},{"key":"4037_CR16","unstructured":"Portal INSST [Internet]. [cited 2025 Apr 21]. Directrices para la decisi\u00f3n cl\u00ednica en enfermedades profesionales - DDC - Portal INSST - INSST. Available from: https:\/\/www.insst.es\/ddc-directrices-para-la-decision-clinica."},{"key":"4037_CR17","unstructured":"Centro de Investigaci\u00f3n en Salud Laboral (CiSAL) [Internet]. [cited 2025 Apr 21]. Centro de Investigaci\u00f3n en Salud Laboral (CiSAL) - Proyecto CEPS. Available from: https:\/\/www.upf.edu\/es\/web\/cisal\/proyecto-ceps."},{"key":"4037_CR18","unstructured":"Garc\u00eda G\u00f3mez M, Urbaneja Arr\u00fae F, Garc\u00eda L\u00f3pez V, Esteban Buedo V, Rodr\u00edguez Su\u00e1rez V, Miralles Mart\u00ednez-Portillo L, et al. Caracter\u00edsticas de los sistemas de comunicaci\u00f3n de las sospechas de enfermedad profesional en las comunidades aut\u00f3nomas. [cited 2025 Apr 21]. Available from: https:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&pid=S1135-57272017000100114."},{"key":"4037_CR19","unstructured":"Ministerio de Trabajo y Asuntos Sociales. Orden TAS\/1\/2007, de 2 de enero, por la que se establece el modelo de parte de enfermedad profesional, se dictan normas para su elaboraci\u00f3n y transmisi\u00f3n y se crea el correspondiente fichero de datos personales [Internet]. Sect. 1, Orden TAS\/1\/2007 Jan 4, 2007 p. 482\u20137. Available from: https:\/\/www.boe.es\/eli\/es\/o\/2007\/01\/02\/tas1."},{"key":"4037_CR20","unstructured":"Vicente Pardo JM, L\u00f3pez-Guill\u00e9n Garc\u00eda A, Vicente Pardo JM, L\u00f3pez-Guill\u00e9n Garc\u00eda A. C\u00e1ncer en poblaci\u00f3n trabajadora. Incapacidad y riesgo de exclusi\u00f3n laboral y social. [cited 2025 Apr 21]. Available from: https:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&pid=S0465-546X2018000400354."},{"key":"4037_CR21","unstructured":"Seguridad Social: Publicaciones [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.seg-social.es\/wps\/portal\/wss\/internet\/Conocenos\/Publicaciones\/28156\/47075\/3615."},{"key":"4037_CR22","unstructured":"Seguridad Social: Publicaciones [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.seg-social.es\/wps\/portal\/wss\/internet\/Conocenos\/Publicaciones\/28156\/47075\/62e20eb4-bd64-47cb-a4ac-b55b39428d9f."},{"key":"4037_CR23","unstructured":"Terradillos-Garcia MJ. Gu\u00eda de valoraci\u00f3n de incapacidad laboral temporal para m\u00e9dicos de atenci\u00f3n primaria (2a edici\u00f3n). [cited 2025 Apr 21]. Available from: https:\/\/repisalud.isciii.es\/entities\/publication\/b093d2bf-d6d1-4006-9e75-f14fc76a98e3."},{"key":"4037_CR24","unstructured":"BOE-A-1997\u20131853 Real Decreto 39\/1997, de 17 de enero, por el que se aprueba el Reglamento de los Servicios de Prevenci\u00f3n. [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-1997-1853."},{"key":"4037_CR25","unstructured":"Consejo General del Poder Judicial: Buscador de contenidos [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.poderjudicial.es\/search\/openDocument\/56e49f04008d0dcf\/20170802."},{"key":"4037_CR26","unstructured":"BOE-A-1995\u201324292 Ley 31\/1995, de 8 de noviembre, de Prevenci\u00f3n de Riesgos Laborales. [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-1995-24292."},{"key":"4037_CR27","unstructured":"Portal INSST [Internet]. [cited 2025 Apr 21]. El INSST lidera la Agencia Nacional de Prevenci\u00f3n del C\u00e1ncer - Portal INSST - INSST. Available from: https:\/\/www.insst.es\/noticias-insst\/el-insst-lidera-la-agenda-nacional-de-prevenci%C3%B3n-del-cancer-de-origen-profesional."},{"key":"4037_CR28","unstructured":":: Academic Journal of Health Sciences\u202f:: Biblioteca Digital de les Illes Balears [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/ibdigital.uib.es\/greenstone\/library\/collection\/medicinaBalear\/document\/AJHS_Medicina_Balear_2021v36n3p009?p.s=TextQuery."},{"key":"4037_CR29","unstructured":"Vicente-Herrero MT, S\u00e1nchez-Herrera Bautista-C\u00e1mara I, Mezquita L, Huertas R\u00edos S, Oubi\u00f1a Albaladejo A, Arteaga R, et al. Visi\u00f3n 360\u00b0 en c\u00e1ncer y trabajo. Gu\u00eda de actuaci\u00f3n. [cited 2025 Apr 21]. Available from: https:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&pid=S3020-11602022000400010."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04037-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:19:12Z","timestamp":1771510752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04037-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4037"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04037-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LM: No other conflicts of interest related to this work have been reported. Outside the scope of this work, LM has participated in the following activities: Consulting\/Advisory Role: Roche, Takeda, Janssen, MSD; Speakers\u2019 Bureau: Bristol Myers Squibb, AstraZeneca, Roche, Takeda, Janssen, Radonova, Daiicki Sankyo; Research Funding: Inivata, AstraZeneca, Gilead; Travel, Accommodations, and Expenses: Bristol Myers Squibb, Roche, AstraZeneca, Takeda, Janssen. MTVH: No other conflicts of interest directly related to the present study have been disclosed. PC: No other conflicts of interest directly related to the present study have been disclosed. MVRI: No other conflicts of interest directly related to the present study have been disclosed. JHC: No other conflicts of interest directly related to the present study have been disclosed. LCG: No other conflicts of interest directly related to the present study have been disclosed. OG: No other conflicts of interest directly related to the present study have been disclosed. AC: No other conflicts of interest directly related to the present study have been disclosed. KM: Employee of AstraZeneca. No other conflicts of interest directly related to the present study have been disclosed. JPA: No other conflicts of interest directly related to the present study have been disclosed. RM: No other conflicts of interest directly related to the present study have been disclosed. MGP: Travel, Accommodations, Expenses: Roche, AstraZeneca, Takeda, Pfizer. LGS: No other conflicts of interest directly related to the present study have been disclosed. Outside the scope of this work, LGS has participated in the following activities: Consulting\/Advisory Role: Roche; Travel, Accommodations, and Expenses: Roche, Pfizer, AstraZeneca, Takeda, Janssen. EM: No other conflicts of interest directly related to the present study have been disclosed. MOA: No other conflicts of interest directly related to the present study have been disclosed. CS: No other conflicts of interest directly related to the present study have been disclosed. MJT: No other conflicts of interest directly related to the present study have been disclosed. MRV: No other conflicts of interest directly related to the present study have been disclosed. LRB: No other conflicts of interest directly related to the present study have been disclosed. CAR: No other conflicts of interest directly related to the present study have been disclosed. Outside the scope of this work, CAR has participated in the following activities: Consulting\/Advisory Role: Roche, Menarini, MSD, Astra-Zeneca, Daiichi-Sankyo. Speakers\u2019 Bureau: Roche, Novartis, Astra-Zeneca, Daiichi-Sankyo, MSD. BCC: No other conflicts of interest directly related to the present study have been disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}